mHealth(モバイルヘルス)のアジア太平洋市場

【英語タイトル】Asia-Pacific mHealth Market by Devices (Blood Glucose Meters, BP Monitors, Pulse oximetry, Neurological Monitoring, Wearable fitness sensor device and Heart Rate Meters) and Service (Diagnosis, Monitoring, Prevention, Treatment, Wellness and healthcare system) - Opportunity Analysis and Industry Forecast, 2014 - 2020

Allied Market Researchが出版した調査資料(AMR8041115)・商品コード:AMR8041115
・発行会社(調査会社):Allied Market Research
・発行日:2016年3月
・ページ数:122
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:アジア
・産業分野:Healthcare
◆販売価格オプション(消費税別)
Single UserUSD3,999 ⇒換算¥431,892見積依頼/購入/質問フォーム
5 UserUSD4,983 ⇒換算¥538,164見積依頼/購入/質問フォーム
Enterprise UserUSD5,583 ⇒換算¥602,964見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Asia Pacific mHealth market projects a remarkable growth rate, supplemented with the growing awareness of mHealth devices and services that aid in improve the quality of life for patients stricken with lifestyle diseases. The growing prevalence of lifestyle diseases such as diabetes, obesity, hypertension, chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA), in Asia Pacific region, creates an impending need of technologically advanced platforms for the prevention and treatment of these diseases. According to the National Institute of Health, China and India are the two highest populated nations, with an approximate diabetes count of 150 million patients. Thus, the need for regular health monitoring and treatment would be addressed by launch of smartphone-based medical devices.
The Asia Pacific mHealth market was evaluated at $2.3 billion in 2014, and is expected to register a CAGR of 35.8% during the forecast period (2015 to 2020). This growth is primarily driven by active government initiatives and the rising adoption of smartphones in Asia-pacific region. Presently, the market is witnessing a resurgence due to the increasing disposable incomes and the growing adoption of mobile phones. Moreover, a similar trend is observed in developing countries like India and Indonesia. However, factors such as consumers affordability, access to healthcare services and inaccuracy in results arising from discrepancies in devices would limit the growth of the market.

Themarket is segmented into devices, services, application, stakeholders and geography. Based on device type, the market is segmented into blood glucose meters, BP monitors, pulse oximetry, neurological monitoring devices, apnea and sleep monitors, wearable fitness sensor device & heart rate meters and others. The BP monitors segment holds a dominant share; however, the blood glucose meters segment is estimated to register the fastest growth in the Asia Pacific mHealth devices market. Factors such as incidences of hypertension, sedentary lifestyles, the increasing count of diabetics, supplement the adoption of mHealth devices. Based on services, the market is segmented into diagnosis services, monitoring services, prevention, treatment and wellness & healthcare system strengthening solutions. The monitoring services segment holds a dominant share in the Asia Pacific mHealth services market and would register the highest CAGR throughout the forecast period (2015-2020). Based on stake holders, the market is segmented into mobile operators, device vendors, healthcare providers and application players. Within the segment of stakeholders, mobile operators occupy a dominant share in themarket. The segment of mobile application developers would register the highest CAGR during the forecast period (2015-2020). Based on applications, the industry is segmented into cardiovascular diseases, diabetes, respiratory diseases, neurological diseases and others. The cardiovascular diseases segment holds a dominant share in the Asia Pacific mHealth applications market; however, the diabetes application segment is expected to register the highest CAGR during the forecast period (2015-2020). Based on country, the market is segmented across Australia, China, Japan, India and Rest of Asia Pacific. China accounts for the largest market share, whilst India is the fastest growing region in thismarket.

The key players profiled in this report include – Philips Healthcare, Omron HealthCare, Inc., Bayer Healthcare, LifeWatch AG, Masimo Corporation, Sanofi S.A., Boston Scientific Corporation, AT&T Inc. and Johnson & Johnson.

KEY BENEFITS

The report covers a detailed quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
Themarket scenario is comprehensively analyzed based on key countries
Key market players are profiled in the report and their strategies are analyzed thoroughly, which helps in understanding the competitive outlook of the market
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework
Comprehensive analysis of factors that drive and restrict the growth of themarket, is provided in the report
Exhaustive analysis of themarket, by device type, helps in understanding the types of devices that are currently being used along with the variants that would gain prominence in future

ASIA PACIFIC mHEALTH MARKET KEY SEGMENTS:

By Devices

Blood glucose meters
BP monitors
Pulse oximetry
Neurological monitoring devices
Apnea and sleep monitors
Wearable fitness sensor device & heart rate meters
Others

By Services

Diagnosis services
Monitoring services
Prevention
Treatment
Wellness and healthcare system strengthening solutions

By Stakeholders

Mobile operators
Device vendors
Healthcare providers
Application players

By Application

Cardiovascular diseases
Diabetes
Respiratory diseases
Neurological diseases
Others

By Country

Australia
China
Japan
India
Rest of Asia-Pacific

【レポートの目次】

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Market segmentation
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top impacting factors
3.2.2 Top investment pockets

3.3 Porters five forces analysis

3.3.1 Bargaining power of buyers
3.3.2 Bargaining power of supplier
3.3.3 Threat of new entrant
3.3.4 Threat of substitute
3.3.5 Intensity of rivalry

3.4 Value chain analysis

3.4.1 Primary activities
3.4.2 Secondary activities

3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Integration of wireless technologies with portable healthcare devices
3.5.1.2 Increase in incidences of lifestyle diseaseS
3.5.1.3 Cost and convenience Factors
3.5.1.4 Technological integration
3.5.1.5 increasing government initiatives
3.5.1.6 Affordability of smartphones

3.5.2 Restraints

3.5.2.1 Lower adoption accross developing economies
3.5.2.2 Weak reimbursement coverage
3.5.2.3 Technological awareness among the ageing population

3.5.3 Opportunities

3.5.3.1 Untapped market of developing economies
3.5.3.2 Rising Opportunities in the form of bundled services

CHAPTER 4 BY DEVICES

4.1 Blood glucose meter

4.1.1 Key Market Trends
4.1.2 Key Growth Factors and Opportunity
4.1.3 Market Size and Forecast

4.2 BP monitors

4.2.1 Key Market Trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Pulse oximetry

4.3.1 Key market trends
4.3.2 Key growth factors and opportunity
4.3.3 Market size and forecast

4.4 Neurological monitoring

4.4.1 Key market trends
4.4.2 Key growth factors and opportunity
4.4.3 Market size and forecast

4.5 Cardiac monitors

4.5.1 Key market trends
4.5.2 Key growth factors and opportunity
4.5.3 Market size and forecast

4.6 Apnea sleep monitors

4.6.1 Key market trends
4.6.2 Key growth factors and opportunity
4.6.3 Market size and forecast

4.7 Wearable fitness sensor device and heart rate meters

4.7.1 Key market trends
4.7.2 Key growth factors and opportunity
4.7.3 Market size and forecast

4.8 Others

4.8.1 Market Size and Forecast

CHAPTER 5 BY SERVICES

5.1 Prevention

5.1.1 Market size and forecast

5.2 Diagnostic services

5.2.1 Market size and forecast

5.3 Monitoring services

5.3.1 Market size and forecast

5.4 Treatment

5.4.1 Market size and forecast

5.5 Wellness and healthcare system strengthening solutions

5.5.1 Market size and forecast

CHAPTER 6 BY STAKEHOLDERS

6.1 Mobile operators

6.1.1 Market size and forecast

6.2 Device vendors

6.2.1 Market Size and Forecast

6.3 Healthcare providers

6.3.1 Market size and forecast

6.4 Application/ content players

6.4.1 Market size and forecast

CHAPTER 7 BY APPLICATION

7.1 Cardiovascular

7.1.1 Market size and forecast

7.2 Diabetes

7.2.1 Market size and forecast

7.3 Respiratory

7.3.1 Market size and forecast

7.4 Neurology

7.4.1 Market size and forecast

7.5 Others

7.5.1 Market size and forecast

CHAPTER 8 BY COUNTRY

8.1 Overview

8.1.1 Key market trends
8.1.2 Key growth factors and opportunities
8.1.3 Market size and forecast

8.2 Australia

8.2.1 Market Size and Forecast

8.3 China

8.3.1 Market Size and Forecast

8.4 Japan

8.4.1 Market Size and Forecast

8.5 India

8.5.1 Market Size and Forecast

8.6 Rest of Asia-Pacific

8.6.1 Market Size and Forecast

CHAPTER 9 COMPANY PROFILS

9.1 LifeWatch AG

9.1.1 Company overview
9.1.2 LifeWatch AG snapshot
9.1.3 Operating business segment overview
9.1.4 Business performance
9.1.5 Strategic moves and development
9.1.6 SWOT analysis of LifeWatch AG

9.2 Masimo Corporation

9.2.1 Company overview
9.2.2 Masimo Corporation snapshot
9.2.3 Operating business segment overview
9.2.4 Business performance
9.2.5 Strategic moves and developments
9.2.6 SWOT analysis of Masimo Corporation

9.3 Omron healthcare Inc.

9.3.1 Company overview
9.3.2 Omron Healthcare Snapshot
9.3.3 Operating business segment overview
9.3.4 Business performance
9.3.5 Strategic moves and developments
9.3.6 SWOT analysis of Omron Healthcare Inc.

9.4 Philips healthcare (a division of Royal Philips company)

9.4.1 Company overview
9.4.2 Philips Healthcare snapshot
9.4.3 Operating business segment overview
9.4.4 Business performance
9.4.5 Strategic moves and developments
9.4.6 SWOT analysis of Philips Healthcare

9.5 Bayer Healthcare (a division of Bayer)

9.5.1 Company overview
9.5.2 Bayer Healthcare snapshot
9.5.3 Operating business segment overview
9.5.4 Business performance
9.5.5 Strategic moves and development
9.5.6 SWOT analysis Of Bayer Healthcare

9.6 Sanofi

9.6.1 Company overview
9.6.2 Sanofi snapshot
9.6.3 Operating business segment overview
9.6.4 Business performance
9.6.5 Strategic moves and developments
9.6.6 SWOT analysis of Sanofi

9.7 Boston Scientific Corporation

9.7.1 Company overview
9.7.2 Boston Scientific Corporation snapshot
9.7.3 Operating business segment
9.7.4 Business performance
9.7.5 Strategic moves and developments
9.7.6 SWOT analysis of Boston Scientific Corporation

9.8 AT&T Inc.

9.8.1 Company overview
9.8.2 AT&T Inc. snapshot
9.8.3 Operating business segment
9.8.4 Business performance
9.8.5 Strategic moves and developments
9.8.6 SWOT analysis of AT&T Inc.

9.9 Johnson & Johnson

9.9.1 Company overview
9.9.2 Johnson & Johnson Inc snapshot
9.9.3 Operating business segment overview
9.9.4 Business performance
9.9.5 Strategic moves and developments
9.9.6 SWOT analysis of Johnson & Johnson.

TABLE 1 GOVERNMENT OF INDIA MHEALTH INITIATIVES
TABLE 2 ASIA-PACIFIC MHEALTH MARKET, BY DEVICES, 2014-2020 ($MILLION)
TABLE 3 ASIA-PACIFIC MHEALTH MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 4 ASIA-PACIFIC MHEALTH BLOOD GLUCOSE METERS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 5 MOBILE COMPATIBLE BP MONITORS
TABLE 6 ASIA-PACIFIC BP MONITORS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 7 AVAILABLE PULSE OXIMETERS AND ITS COST
TABLE 8 ASIA-PACIFIC PULSE OXIMETRY MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 9 ESTIMATED PEOPLE WITH DEMENTIA IN ASIA-PACIFIC REGION
TABLE 10 ASIA-PACIFIC MHEALTH NEUROLOGICAL DEVICES MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 11 ASIA-PACIFIC MHEALTH CARDIAC MONITORS MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 12 SLEEP APNEA DEVICES
TABLE 13 ASIA-PACIFIC MHEALTH APNEA SLEEP MONITORS MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 14 WEARABLE FITNESS DEVICES AND ITS COST
TABLE 15 ASIA-PACIFIC WEARABLE FITNESS SENSORS DEVICES AND HEART RATE METERS MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 16 ASIA-PACIFIC MHEALTH OTHER DEVICES MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 17 ASIA-PACIFIC MHEALTH SERVICES MARKET, BY TYPE, 2014-2020 ($MILLION)
TABLE 18 ASIA-PACIFIC MHEALTH SERVICES MARKET, BY COUNTRY,, 2014-2020 ($MILLION)
TABLE 19 SMARTPHONE APPS FOR PREVENTIVE SERVICES
TABLE 20 MOBILE HEALTHCARE SOLUTION PROVIDED BY CDAC
TABLE 21 ASIA-PACIFIC MHEALTH PREVENTION SERVICE MARKET, BY COUNTRY, 2014 2020 ($MILLION)
TABLE 22 ASIA-PACIFIC MHEALTH DIAGNOSIS SERVICE MARKET, BY COUNTRY, 2014 2020 ($MILLION)
TABLE 23 ASIA-PACIFIC MHEALTH MONITORING SERVICE MARKET, BY COUNTRY, 2014 2020 ($MILLION)
TABLE 24 ASIA-PACIFIC MHEALTH TREATMENT SERVICE MARKET, BY COUNTRY, 2014 2020 ($MILLION)
TABLE 25 ASIA-PACIFIC MHEALTH WELLNESS AND HEALTHCARE SYSTEMS STRENGTHENING SOLUTIONS MARKET, BY COUNTRY, 2014 2020 ($MILLION)
TABLE 26 ASIA-PACIFIC MHEALTH MARKET, BY STAKEHOLDERS,2014 2020 ($MILLION)
TABLE 27 ASIA-PACIFIC MHEALTH STAKEHOLDERS MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 28 ASIA-PACIFIC MHEALTH MOBILE OPERATORS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 29 ASIA-PACIFIC MHEALTH DEVICE VENDORS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 30 ASIA-PACIFIC MHEALTH HEALTHCARE PROVIDERS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 31 ASIA-PACIFIC MHEALTH APPLICATION/CONTENT PLAYERS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 32 ASIA-PACIFIC MHEALTH MARKET BY APPLICATION, 2014 2020 ($MILLION)
TABLE 33 ASIA-PACIFIC MHEALTH APPLICATION MARKET BY COUNTERY, 2014-2020, ($MILLION)
TABLE 34 ASIA-PACIFIC MHEALTH CARDIOVASCULAR APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 35 PREVALENCE AND PROJECTIONS OF DIABETES IN ASIA-PACIFIC REGION
TABLE 36 ASIA-PACIFIC MHEALTH DIABETES APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 37 ASIA-PACIFIC MHEALTH RESPIRATORY APPLICATION MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 38 ASIA-PACIFIC NUMBER OF DALYS FOR NEUROLOGICAL DISORDERS PROJECTION FOR 2015 AND 2030
TABLE 39 ASIA-PACIFIC MHEALTH NEUROLOGY APPLICATION MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 40 ASIA-PACIFIC MHEALTH OTHER APPLICATIONS MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 41 IMPACT ANALYSIS PENETRATING TO ASIA-PACIFIC COUNTRIES 2014
TABLE 42 ASIA-PACIFIC MHEALTH MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 43 AUSTRALIA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 44 CHINA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 45 JAPAN MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
TABLE 46 INDIA MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
TABLE 47 REST OF ASIA-PACIFIC MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 48 LIFEWATCH AG COMPANY SNAPSHOT
TABLE 49 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 50 MASIMO CORPORATION SNAPSHOT
TABLE 51 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 52 OMRON HEALTHCARE SNAPSHOT
TABLE 53 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 54 PHILIPS HEALTHCARE SNAPSHOT
TABLE 55 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 56 BAYER HEALTHCARE SNAPSHOT
TABLE 57 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 58 SANOFI SNAPSHOT
TABLE 59 OPERATING BUSINESS SEGMENTS OVERVIEW
TABLE 60 BOSTON SCIENTIFIC CORPORATION SNAPSHOT
TABLE 61 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 62 AT&T INC. SNAPSHOT
TABLE 63 OPERATING BUSIMESS SEGMENT OVERVIEW
TABLE 64 JOHNSON & JOHNSON INC SNAPSHOT
TABLE 65 OPERATING BUSINESS SEGMENT OVERVIEW

FIG. 1 TOP FACTORS IMPACTING ASIA-PACIFIC MHEALTH MARKET (2014-2020)
FIG. 2 TOP INVESTMENT POCKETS IN ASIA-PACIFIC MHEALTH MARKET (2014-2020)
FIG. 3 PORTERS FIVE FORCES ANALYSIS
FIG. 4 VALUE CHAIN ANALYSIS OF ASIA-PACIFIC MHEALTH MARKET
FIG. 5 PENETRATION OF SMARTPHONE USERS
FIG. 6 COST AND MANUFACTURERS OF HEART RATE MONITORS
FIG. 7 MORTALITY INCIDENCES OF CVD (2010-2030)
FIG. 8 ASTHMA PREVALENCE IN UNITED STATES IN 2011
FIG. 9 BUSINESS PERFORMANCE OF LIFEWATCH 2012-2014 ($MILLION)
FIG. 10 REVENUE BY REGION (2014)
FIG. 11 SWOT ANALYSIS OF LIFEWATCH AG
FIG. 12 BUSINESS PERFORMANCE OF MASIMO CORPORATION 2012-2014 ($MILLION)
FIG. 13 SWOT ANALYSIS OF MASIMO CORPORATION
FIG. 14 NET SALES OF OMRON HEALHCARE ($MILLION)
FIG. 15 NET SALES OF OMRON HEALTHCARE OPERATING SEGMENT (2013)
FIG. 16 NET SALES OF OMRON HEALTHCARE BY REGION (2013)
FIG. 17 SWOT ANALYSIS OF OMRON HEALTHCARE INC.
FIG. 18 PHILIPS HEALTHCARE NET SALES 2012-2014 ($MILLION)
FIG. 19 PHILIPS HEALTHCARE REVENUE BY OPERATING SEGMENT (2014)
FIG. 20 SWOT ANALYSIS OF PHILIPS HEALTHCARE
FIG. 21 NET SALES OF BAYER HEALTHCARE 2012-2014 ($MILLION)
FIG. 22 BAYER HEALTHCARES REVENUE BY OPERATING SEGMENT IN 2014
FIG. 23 SWOT ANALYSIS OF BAYER HEALTHCARE
FIG. 24 NET SALES OF SANOFI 2012-2014 ($MILLION)
FIG. 25 NET SALES OF SANOFI BY OPERATING SEGMENT (2014)
FIG. 26 NET SALES OF SANOFI BY GEOGRAPHY 2014
FIG. 27 SWOT ANALYSIS OF SANOFI
FIG. 28 OPERATIONAL SALES OF BOSTON SCIENTIFIC 2012-2014 ($MILLION)
FIG. 29 OPERATIONAL SALES BY OPERATING SEGMENT 2014
FIG. 30 SWOT ANALYSIS OF BOSTON SCIENTIFIC CORPORATION
FIG. 31 REVENUE OF AT&T INC. 2012-2014 ($MILLION)
FIG. 32 SWOT ANALYSIS OF AT&T INC.
FIG. 33 NET SALES OF JOHNSON & JOHNSON 2012-2014 ($MILLION)
FIG. 34 NET SALES BY OPERATING SEGMENT 2014
FIG. 35 SWOT ANALYSIS OF JOHNSON & JOHNSON.

★調査レポート[mHealth(モバイルヘルス)のアジア太平洋市場] (コード:AMR8041115)販売に関する免責事項を必ずご確認ください。
★調査レポート[mHealth(モバイルヘルス)のアジア太平洋市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆